Subbu Ramanarayanan is an experienced antitrust expert and an adjunct associate professor of competitive strategy at the UCLA Anderson School of Management. Dr. Ramanarayanan has extensive experience advising clients on antitrust reviews of proposed mergers and acquisitions before federal (FTC and DOJ) and state antitrust agencies. He is particularly experienced in the analysis of large and complex transactions, including advising on horizontal, vertical, and cross-market issues raised by antitrust agencies in such matters. He has also testified as the lead economic expert on antitrust matters, including in merger challenges brought by the agencies. Dr. Ramanarayanan testified on behalf of the merging parties in the FTC’s challenge of the merger between Albert Einstein Health Network and Thomas Jefferson University, which was the first time the FTC lost a hospital merger challenge in nearly two decades.
Dr. Ramanarayanan is particularly well known for his in-depth experience studying competition in healthcare and related industries, including medical devices, pharmaceutical distribution, healthcare IT and data analytics services, and dialysis services. In addition to analyzing horizontal mergers, his recent work has included analyzing the competitive impact of vertical transactions and “roll ups” in these sectors.
Dr. Ramanarayanan is recognized as one of the “most highly regarded” Future Leaders in Who’s Who Legal: Competition and is a two-time winner of the Lexology/Client Choice award in the Competition Economists – USA category. He is an associate editor of the Antitrust Law Journal and has written extensively on the nature of competition in healthcare markets and its impact on healthcare costs and quality. He has published articles in the Antitrust Law Journal and Antitrust Magazine, as well as leading peer-reviewed economics journals such as the American Economic Review and the Journal of Law and Economics. Notably, he is a two-time winner of the Antitrust Writing Award from the Institute of Competition Law for his articles examining potential competition mergers (2017) and innovation effects of mergers (2019).